研究设计与统计指南

订阅

MedSci主页 / 所有栏目 / 研究设计与统计指南

CONSORT 2010 声明：扩展到随机交叉试验

2021-09-01 Equator Network BMJ . 2019 Jul 31;366:l4378. doi: 10.1136/bmj.l4378

CONSORTCONSORT声明

证据表明随机对照试验的报告质量不是最佳的。缺乏透明的报告会阻碍读者判断试验结果的可靠性和有效性，阻碍研究人员为系统评价提取信息，导致研究浪费。制定报告试验的统一标准 (CONSORT) 声明是为了改进

中文标题：

CONSORT 2010 声明：扩展到随机交叉试验

英文标题：

CONSORT 2010 statement: extension to randomised crossover trials

发布机构：

Equator Network

发布日期：

2021-09-01

简要介绍：

证据表明随机对照试验的报告质量不是最佳的。缺乏透明的报告会阻碍读者判断试验结果的可靠性和有效性，阻碍研究人员为系统评价提取信息，导致研究浪费。制定报告试验的统一标准 (CONSORT) 声明是为了改进随机对照试验的报告。该声明的主要重点是两个治疗组的平行组试验。交叉试验是一种特殊类型的慢性病试验，参与者被随机分配到一系列干预措施中。它们是一种有用且高效的设计，因为参与者充当他们自己的控制者。然而，交叉试验的报告多变且不完整，这阻碍了它们在临床决策和未来研究人员中的使用。我们将 CONSORT 扩展到随机交叉试验，旨在促进更好地报告交叉试验。 CONSORT 2010 检查表针对交叉设计进行了修订，并引入了经过修改的流程图和基线表以提高透明度。提供了 CONSORT 交叉检查表项目的良好报告和基于证据的理由的示例。

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3c2e51c0021e235d, title=CONSORT 2010 声明：扩展到随机交叉试验 , enTitle=CONSORT 2010 statement: extension to randomised crossover trials, guiderFrom=BMJ . 2019 Jul 31;366:l4378. doi: 10.1136/bmj.l4378, authorId=0, author=, summary=证据表明随机对照试验的报告质量不是最佳的。缺乏透明的报告会阻碍读者判断试验结果的可靠性和有效性，阻碍研究人员为系统评价提取信息，导致研究浪费。制定报告试验的统一标准 (CONSORT) 声明是为了改进, cover=, journalId=0, articlesId=null, associationId=1954, associationName=Equator Network, associationIntro=equator-network, copyright=0, guiderPublishedTime=Wed Sep 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">证据表明随机对照试验的报告质量不是最佳的。缺乏透明的报告会阻碍读者判断试验结果的可靠性和有效性，阻碍研究人员为系统评价提取信息，导致研究浪费。制定报告试验的统一标准 (CONSORT) 声明是为了改进随机对照试验的报告。该声明的主要重点是两个治疗组的平行组试验。交叉试验是一种特殊类型的慢性病试验，参与者被随机分配到一系列干预措施中。它们是一种有用且高效的设计，因为参与者充当他们自己的控制者。然而，交叉试验的报告多变且不完整，这阻碍了它们在临床决策和未来研究人员中的使用。我们将 CONSORT 扩展到随机交叉试验，旨在促进更好地报告交叉试验。 CONSORT 2010 检查表针对交叉设计进行了修订，并引入了经过修改的流程图和基线表以提高透明度。提供了 CONSORT 交叉检查表项目的良好报告和基于证据的理由的示例。</span></span></p>, tagList=[TagDto(tagId=10687, tagName=CONSORT), TagDto(tagId=30463, tagName=CONSORT声明)], categoryList=[CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=87, categoryName=论文与基金, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3921, appHits=50, showAppHits=0, pcHits=478, showPcHits=3871, likes=0, shares=3, comments=3, approvalStatus=1, publishedTime=Wed Sep 01 23:26:06 CST 2021, publishedTimeString=2021-09-01, pcVisible=1, appVisible=1, editorId=4754896, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=小小医者, createdTime=Wed Sep 01 23:23:21 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 22:05:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1232028, encodeId=6603123202840, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51602193824, createdName=1209ca2cm87暂无昵称, createdTime=Tue Jul 12 16:36:30 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082294, encodeId=b0df1082294ae, content=很好，给了我们很多便利, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Tue Dec 21 00:56:32 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013612, encodeId=d26a101361255, content=很好，给了我们很多便利, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e48e5415305, createdName=ms4000000407588115, createdTime=Wed Sep 01 23:47:29 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
    2022-07-12 1209ca2cm87暂无昵称

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1232028, encodeId=6603123202840, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51602193824, createdName=1209ca2cm87暂无昵称, createdTime=Tue Jul 12 16:36:30 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082294, encodeId=b0df1082294ae, content=很好，给了我们很多便利, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Tue Dec 21 00:56:32 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013612, encodeId=d26a101361255, content=很好，给了我们很多便利, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e48e5415305, createdName=ms4000000407588115, createdTime=Wed Sep 01 23:47:29 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
    2021-12-21 一己怀

    很好，给了我们很多便利

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1232028, encodeId=6603123202840, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=51602193824, createdName=1209ca2cm87暂无昵称, createdTime=Tue Jul 12 16:36:30 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082294, encodeId=b0df1082294ae, content=很好，给了我们很多便利, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Tue Dec 21 00:56:32 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013612, encodeId=d26a101361255, content=很好，给了我们很多便利, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e48e5415305, createdName=ms4000000407588115, createdTime=Wed Sep 01 23:47:29 CST 2021, time=2021-09-01, status=1, ipAttribution=)]
    2021-09-01 ms4000000407588115

    很好，给了我们很多便利

    0

相关指南

CONSORT 2010 解释和详细说明：更新的平行组随机试验报告指南

Equator Network · 2021-09-01

非药物治疗随机试验的 CONSORT 声明：2017 年更新和非药物试验摘要的 CONSORT 扩展

Equator Network · 2021-09-01